[Form 4] Option Care Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Option Care Health director Timothy P. Sullivan reported an open-market purchase of common stock on 08/21/2025. The Form 4 shows a purchase (transaction code P) of 20,000 shares at $27.51 per share, bringing his beneficial ownership to 49,229 shares, held directly. The filing was signed on behalf of Mr. Sullivan by an attorney-in-fact, Michael Shapiro.

Positive

• Director purchase of 20,000 OPCH shares reported, signaling insider buying activity
• Transaction details disclosed fully: date (08/21/2025), price ($27.51), and post-transaction ownership (49,229 shares)
• Form 4 filed and signed by attorney-in-fact, indicating proper execution of required disclosure

Negative

• None.

Insights

Securities Analyst

TL;DR: Director purchased 20,000 OPCH shares, modestly increasing his direct stake to 49,229 shares.

The reported transaction is a straightforward open-market purchase by a company director recorded on a Form 4. At $27.51 per share for 20,000 shares, the filing documents an increase in direct beneficial ownership that is routine for insiders and does not on its face indicate a material corporate event. The signature by an attorney-in-fact is standard when the insider delegates filing execution. For investors, this is an insider purchase signal but the filing alone lacks context on timing, plan (e.g., 10b5-1) or proportional ownership relative to outstanding shares, so its material impact is likely limited.

Corporate Governance Expert

TL;DR: Governance disclosure is complete and routine; no governance red flags in this Form 4.

The Form 4 cleanly discloses the reporting person, relationship to issuer (Director), transaction date, transaction code (P), number of shares acquired, price, and post-transaction ownership. The absence of amendment dates or unusual transaction codes suggests a compliant, ordinary disclosure. The filing does not state whether the purchase was executed under a trading plan, so no inference should be made about intent. From a governance perspective, the document satisfies Section 16 reporting requirements and does not raise procedural concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SULLIVAN TIMOTHY P

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2025		P		20,000	A	$27.51	49,229	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Michael Shapiro, attorney-in-fact for Mr. Sullivan	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Timothy P. Sullivan disclose on the Form 4 for OPCH?

The filing discloses a purchase of 20,000 shares of Option Care Health on 08/21/2025 at $27.51 per share, resulting in 49,229 shares beneficially owned directly.

Does the Form 4 indicate the purchase was made under a 10b5-1 trading plan?

The Form 4 does not indicate that the transaction was made pursuant to a 10b5-1 plan; no box or plan reference is specified in the provided content.

What is the reporting person's relationship to Option Care Health (OPCH)?

The reporting person, Timothy P. Sullivan, is identified as a Director of Option Care Health, Inc.

How much did the reported transaction cost at the disclosed price?

At $27.51 per share for 20,000 shares, the transaction amount was $550,200 (20,000 × $27.51).

Who signed the Form 4 filing?

The Form 4 was signed on behalf of Mr. Sullivan by Michael Shapiro, attorney-in-fact on 08/21/2025.